TNRAX Performance — 1290 Avantis U.S. Large Cap Growth, Class A
Data updated: 2026-09-25
TNRAX returned +6.20% year to date and +14.64% over one year to Jul 2026. Over one year the fund beat its Moderate Allocation category average: $100 grew to $115, against $112 for the category. Volatility over the past 12 months was 15.22% a year. In the 12 months to Jul 2026 the fund lost a net $9.7M, and assets reached $209.06M.
TNRAX Growth of $100
What $100 invested in 1290 Avantis U.S. Large Cap Growth grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Moderate Allocation category average over the same months.
| Period | TNRAX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $115 | $112 |
| Since data start (Dec 2023 – Jul 2026) | $169 | $134 |
TNRAX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.20% |
| 1 year | +14.64% |
3- and 5-year figures withheld: too few months to verify.
TNRAX Annual Returns
Calendar-year total returns of 1290 Avantis U.S. Large Cap Growth, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.20% |
| 2025 | +16.74% |
| 2024 | +29.81% |
| 2023 (Dec–Dec) | +4.84% |
TNRAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.5% | −2.1% | −5.2% | +11.2% | +5.6% | −2.7% | −0.3% | — | — | — | — | — |
| 2025 | +2.1% | −3.2% | −8.0% | +0.5% | +8.2% | +5.9% | +3.3% | +1.2% | +4.5% | +3.3% | −1.0% | −0.3% |
| 2024 | +2.8% | +7.1% | +2.3% | −4.7% | +5.8% | +5.1% | −1.2% | +1.8% | +2.8% | −0.5% | +6.1% | −0.3% |
| 2023 | — | — | — | — | — | — | — | — | — | — | — | +4.8% |
TNRAX Risk
Risk measures from monthly returns over Aug 2025 – Jul 2026.
- 1-year volatility (annualised): 15.22%
- Best month: +11.23% (Apr 2026)
- Worst month: −5.21% (Mar 2026)
TNRAX Fund Flows
Monthly money in and out of 1290 Avantis U.S. Large Cap Growth, from SEC Form N-PORT.
- 12-month net flow: −$9.7M
- 12-month gross sales (incl. reinvestments): $19.4M
- Sales ÷ redemptions: 0.67×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $1.2M | $2.1M | −$973K |
| Jun 2026 | $1.2M | $1.6M | −$385K |
| May 2026 | $1.4M | $5.3M | −$3.9M |
| Apr 2026 | $1.3M | $2.3M | −$1.1M |
| Mar 2026 | $1.9M | $1.8M | $101K |
| Feb 2026 | $1.3M | $1.5M | −$199K |
| Jan 2026 | $1.4M | $1.9M | −$516K |
| Dec 2025 | $4.1M | $2.1M | $1.9M |
| Nov 2025 | $975K | $3.0M | −$2.0M |
| Oct 2025 | $1.8M | $2.7M | −$809K |
| Sep 2025 | $1.5M | $1.7M | −$144K |
| Aug 2025 | $1.3M | $3.1M | −$1.8M |
TNRAX Assets Under Management
Net assets of 1290 Avantis U.S. Large Cap Growth by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $209.06M |
| 2026-04-30 | $209.09M |
| 2026-01-31 | $203.59M |
| 2025-10-31 | $209.22M |
| 2025-07-31 | $193.98M |
| 2025-04-30 | $168.81M |
| 2025-01-31 | $185.82M |
| 2024-10-31 | $174.29M |
| 2024-07-31 | $169.57M |
| 2024-04-30 | $53.60M |
| 2024-01-31 | $27.11M |
| 2023-10-31 | $6.00M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.